CHEO Research Institute Logo
Decrease Text SizeIncrease Text SizeFacebookTwitterYoutube

photo of researcher holding a beaker

Ann Sprague photo of Ann Sprague
Scientific Manager, BORN Ontario
Scientist, CHEO Research Institute
Clinical Investigator, Ottawa Hospital Research Institute
Adjunct Professor, University of Ottawa, School of Nursing and Faculty of Graduate and Postdoctoral Studies
Adjunct Professor, Queen’s University

asprague@bornontario.ca
613-737-7600 Ext. 6011
Research Practice Areas:
Current Research:
H1N1 Research – We are following the children born during the H1N1 pandemic and looking for differences in hospitalization rates and respiratory illnesses based on maternal vaccination status.

Quality Improvement and Health Services Research – Implementation and evaluation of large scale provincial projects such as clinical dashboards and fetal fibronectin testing.

Database Research – Answering questions and hypothesis testing related to data collected in the BORN Information System.

Supporting the work of graduate students and external and internal research teams – Collaborating on projects related to prenatal care, obesity, diabetes, smoking, implementation of hyperbilirubinemia guidelines, cesarean section, improved ascertainment of congenital anomalies.
Biography:
Since March of 2009, Ann has been the Scientific Manager for BORN Ontario. Ann has a long history of involvement in maternal child care initiatives at the regional, national, and international levels. She has an excellent track record with grant applications, publications, project and team leadership, and mentoring of students. She has a PhD from the University of Alberta and currently serves at the University of Ottawa as an adjunct professor. Currently, she conducts health services research and database research. She also has a keen interest in privacy related to health databases and the protection of personal health information.
Sample Publications:
Dunn SD, Sprague A.E., Fell DB, Harrold J, Walker MC, Dy J, Lamontagne B. The Use of a Quality Indicator to Reduce Elective Repeat Cesarean Section for Low Risk Women Before 39 Weeks Gestation: The Ontario Experience. J Obstet Gynaecol Can 2013;35(4):306–316.

Kelly S, Sprague A.E., Fell DB, Murphy P, Aelicks N, Guo Y, Lauzon L, Scott H, Lee L, Kinniburgh B, Prince M, Walker M. Examining Caesarean Section Rates in Canada Using the Robson Classification System. J Obstet Gynaecol Can 2013;35(3):206–214.

Sprague A.E., Dunn SI, Fell DB, Harrold J, Walker MC, Kelly SK, Smith GN. Measuring Quality in Maternal-Newborn Care: Developing a Clinical Dashbord. J Obstet Gynaecol Can 2013;35(1):29–38.

Xie HY, Yasseen AS 3rd, Xie RH, Fell DB, Sprague A.E., Liu N, Smith GN, Walker MC, Wen SW. Infant Outcomes Among Pregnant Women Who Used Oseltamivir for Treatment of Influenza During the H1N1 Epidemic. Am J of Obstet Gynecol 2013;208(4):293 e1-7.

Liu N, Sprague A.E., Yasseen III AS, Fell DB, Wen SW, Smith GN, Walker MC. Vaccination Patterns in Pregnant Women During the 2009 H1N1 Influenza Pandemic. Can J Public Health 2012;103(25): 353-358
 
Fell, D.B, Sprague A.E., et al. H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes. American Journal of Public Health. Online Ahead of print April 19, 2012.

Sprague A.E., Oppenheimer, L., McCabe, L., Graham, I., & Davies, B. Knowledge to action: Implementing a guideline for second stage labour. MCN, 33(3), 179-186.
 
Take Action
Quick Links

Our Researchmagnifying glass

abcefg hijklmnopqrst uvwxyz